Skip to main content

First IL-23 blocker, guselkumab, earns FDA approval for psoriasis

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
First IL-23 blocker, guselkumab, earns FDA approval for psoriasis

User login

Username

Password

Reset your password

Type	Lead	score